株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療用コールドチェーン・ロジスティクスの世界市場の分析・予測 (2016〜2020年)

Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)

発行 IMARC Services Pvt. Ltd. 商品コード 328219
出版日 ページ情報 英文 112 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
医療用コールドチェーン・ロジスティクスの世界市場の分析・予測 (2016〜2020年) Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)
出版日: 2015年04月06日 ページ情報: 英文 112 Pages
概要

医療用コールドチェーン・ロジスティクスサービスの世界市場は現在、温度感受性の高い医薬品の売上高増加などを受けて、急成長の最中にあります。全世界の医療用コールドチェーン・ロジスティクスの市場規模は、現在の85億米ドルから、2020年には約134億米ドルにまで拡大する、と予測されています。

当レポートでは、世界の医療・製薬産業向けコールドチェーン・ロジスティクスサービスのについて分析し、医療用コールドチェーンの構造・特性や流通プロセス、ロジスティクス上での要件 (温度感受性の高い医薬品の取り扱い方など)、全体的な市場動向の見通し、部門別の詳細動向、主要企業のプロファイルといった情報を盛り込んでお届けいたします。

第1章 調査手法・市場定義

第2章 エグゼクティブサマリー

第3章 世界の医療コールドチェーン・ロジスティクスサービス市場:現在の動向

  • 医療用コールドチェーン製品の急激な成長
  • 温度感受性の高い医薬品の登場による、ロジスティクス上のニーズの顕在化
  • 研究・製造工程のアウトソーシング化傾向による、ロジスティクス上の需要の拡大
  • 輸送された医薬品の保存性に対する、規制面での関心の増大
  • サプライヤーの意思決定において、コストが常に最重要だというわけではない

第4章 医療用コールドチェーン・ロジスティクス:どうやって運用するのか?

  • コールドチェーンの包装・輸送手段
    • ドライアイス
    • 液体窒素
    • ゲルパック
  • コールドチェーンの設定
    • 初期の考察
    • 適切なモデルの選択
    • 規制/通関手続き
    • 最終段階
    • 品質保証
  • コールドチェーンの包装・輸送コストのモデリング

第5章 医療用コールドチェーン・ロジスティクスサービス市場

  • 現在の市場動向
  • 製品別の市場区分
  • セグメント別の市場区分
    • 輸送
      • 現在・過去の市場動向
      • 輸送手段別の市場区分
      • 市場予測
    • 包装
    • 測定装置
  • 地域別の市場区分
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他の地域 (ROW)

第6章 世界の医療用コールドチェーン製品市場

  • 過去・現在・将来の市場動向
  • 市場のセグメント
    • バイオ医薬品
      • 過去・現在・将来の市場動向
      • バイオ医薬品向けコールドチェーンの要件
      • バイオ医薬品向けコールドチェーンの市場機会
    • ワクチン
    • 治験材料

第7章 医療コールドチェーンロジスティクス市場における課題

第8章 温度感受性の高い医薬品の国際貿易

  • 温度感受性の高い医薬品の輸出額
    • 現在・過去の市場動向
    • 主要輸出国
  • 温度感受性の高い医薬品の輸入額
    • 現在・過去の市場動向
    • 主要輸入国

第9章 主要企業のプロファイル

  • World Courier
  • DHL
  • Fedex
  • United Parcel Service
  • Kuehne and Nagel
  • Cavalier Logistics
  • DB Schenker
  • Life ConEx
  • American Airlines Cargo
  • Continental Air Cargo
  • Marken

図表一覧

目次
Product Code: SRHL0415A

Driven by a strong growth in the sales of temperature sensitive healthcare products, the demand for cold chain logistic services is currently experiencing explosive growth. IMARC Group, one of the world's leading research and advisory firms, finds that the total size of the healthcare cold chain logistic services market is expected to expand from its current figures of US$ 8.5 billion to nearly US$ 13.4 billion by 2020.

IMARC's new report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)”, which is the fourth edition of our highly acclaimed publication, provides a comprehensive insight into the logistic opportunities in the global healthcare market. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three key aspects of the global healthcare cold chain logistics market.The first aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The second aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments. The third aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes.

What we have achieved in this report?

Understanding the Healthcare Cold Chain Distribution Process

Focus of the Analysis:

  • Understanding the various methods of cold chain distribution and their advantages/disadvantages
  • Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions
  • Understanding the key steps required in the setting and organization of an efficient cold chain distribution process
  • Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation

Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market

Focus of the analysis:

  • Analyzing and evaluating the global healthcare cold chain logistic services market
  • Analyzing and evaluating the global healthcare cold chain logistic services market by product
    • Biopharmaceuticals
    • Vaccines
    • Clinical trials
  • Analyzing and evaluating the global healthcare cold chain logistic services by segment
    • Transportation
    • Packaging
    • Instrumentation
  • Analyzing and evaluating the global healthcare cold chain logistic services market by Region
    • North America
    • Europe
    • Asia Pacific

Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:

Classes Covered: Biopharmaceuticals, Vaccines and Clinical Trial Materials

Focus of the Analysis in Each Class:

  • Drivers and challenges
  • Historical and future sales trends
  • Logistic requirements
  • Impact of temperature excursions
  • Opportunities in cold chain services

Table of Contents

1. Research Methodology & Market Definitions

2. Executive Summary

3. Current Trends in the Global Healthcare Cold Chain Logistic Services Market

  • 3.1. Healthcare Cold Chain Products are Exhibiting Exponential Growth
  • 3.2. Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
  • 3.3. Outsourcing Trends in Research and Manufacturing Have Increased Logistic Demands
  • 3.4. Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
  • 3.5. Cost is Not Always the Most Important Driver in Supplier Decisions

4. Healthcare Cold Chain Logistics: How Does It Operate?

  • 4.1. Cold Chain Packaging and Transportation Methods
    • 4.1.1. Dry Ice
    • 4.1.2. Liquid Nitrogen
    • 4.1.3. Gel Packs
  • 4.2. Setting Up a Cold Chain
    • 4.2.1. Initial Considerations
    • 4.2.2. Choosing the Correct Model
    • 4.2.3. Regulatory/Custom Clearance
    • 4.2.4. Final Stages
    • 4.2.5. Quality Assurance
  • 4.1. Modeling the Cost of Cold Chain Packaging and Transportation

5. The Healthcare Cold Chain Logistic Services Market

  • 5.1. Current Market Trends
  • 5.2. Market Breakup by Product
    • 5.2.1. Clinical Trial Materials
    • 5.2.2. Vaccines
    • 5.2.3. Biopharmaceuticals
  • 5.3. Market Breakup by Segment
    • 5.3.1. Transportation
      • 5.3.1.1. Current and Historical Market Trends
      • 5.3.1.2. Market Breakup by Transportation Type
      • 5.3.1.3. Market Forecast
    • 5.3.2. Packaging
      • 5.3.2.1. Current and Historical Market Trends
      • 5.3.2.2. Market Breakup by Packaging Type
      • 5.3.2.3. Market Forecast
    • 5.3.3. Instrumentation
      • 5.3.3.1. Current and Historical Market Trends
      • 5.3.3.1. Market Breakup by Instrumentation Type
      • 5.3.3.1. Market Forecast
      • 5.4. Market Breakup by Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. The Global Healthcare Cold Chain Products Market

  • 6.1. Historical, Current and Future Market Trends
  • 6.2. Market Segments
    • 6.2.1. Biopharmaceuticals
      • 6.2.1.1. Historical, Current and Future Market Trends
      • 6.2.1.2. Cold Chain Requirements for Biopharmaceuticals
      • 6.2.1.3. Cold Chain Opportunities for Biopharmaceuticals
    • 6.2.2. Vaccines
      • 6.2.2.1. Historical, Current and Future Market Trends
      • 6.2.2.2. Cold Chain Requirements for Vaccines
      • 6.2.2.3. Cold Chain Opportunities for Vaccines
    • 6.2.3. Clinical Trial Materials
      • 6.2.3.1. Historical, Current and Future Market Trends
      • 6.2.3.2. Cold Chain Requirements for Clinical Trial Materials
      • 6.2.3.3. Cold Chain Opportunities for Clinical Trial Materials

7. Challenges in the Healthcare Cold Chain Logistics Market

8. Global Trade of Temperature Sensitive Healthcare Products

  • 8.1. Global Exports of Temperature Sensitive Healthcare Products
    • 8.1.1. Current and Historical Trends
    • 8.1.2. Major Exporting Countries
  • 8.2. Global Imports of Temperature Sensitive Healthcare Products
    • 8.2.1. Current and Historical Trends
    • 8.2.2. Major Importing Countries

9. Key Company Profiles

  • 9.1. World Courier
  • 9.2. DHL
  • 9.3. Fedex
  • 9.4. United Parcel Service
  • 9.5. Kuehne and Nagel
  • 9.6. Cavalier Logistics
  • 9.7. DB Schenker
  • 9.8. Life ConEx
  • 9.9. American Airlines Cargo
  • 9.10. Continental Air Cargo
  • 9.11. Marken

List of Figures

  • Figure 3.1: Global-Healthcare Cold & Non Cold Chain Products Market (in Billion US$), 2007-2014
  • Figure 3.2: Global-Healthcare Cold & Non Cold Chain Products Market Forecast (in Billion US$), 2015-2020
  • Figure 3.3: Global-Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
  • Figure 3.4: Global-Contract Research & Manufacturing Market (in Billion US$), 2009-2014
  • Figure 3.5: Global-Contract Research & Manufacturing Market Forecast (in Billion US$), 2015-2020
  • Figure 3.6: Estimated Costs incurred in Various Pharmaceutical Operations
  • Figure 4.1: A Typical Drug Supply Chain from the Manufacturer to the End User
  • Figure 5.1: Global-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.2: Global-Healthcare Non Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.3: Global-Healthcare Logistic Services Market, Share of Cold-Chain and Non Cold-Chain Services*, (in %), 2014
  • Figure 5.4: Global-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.5: Global-Healthcare Non Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.6: Global-Healthcare Logistic Services Market Forecast, Share of Cold-Chain and Non Cold-Chain Services*, (in %), 2020
  • Figure 5.7: Global-Healthcare Cold Chain Logistic Services Market by Product (in %), 2014 and 2020
  • Figure 5.8: Global-Clinical Trial Materials Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.9: Global-Clinical Trial Materials Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.10: Global-Vaccines Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.11: Global-Vaccines Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.12: Global-Biopharmaceuticals Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.13: Global-Biopharmaceuticals Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.14: Global-Healthcare Cold Chain Logistic Services Market by Segment (in %), 2014 and 2020
  • Figure 5.15: Global-Healthcare Cold Chain Transportation Services Market (in Billion US$), 2004-2014
  • Figure 5.16: Global-Healthcare Cold Chain Transportation Services Market: Breakup by Transportation Mode (in %), 2014
  • Figure 5.17: Global-Healthcare Cold Chain Transportation Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.18: Global-Healthcare Cold Chain Packaging Services Market (in Billion US$), 2004-2014
  • Figure 5.19: Global-Healthcare Cold Chain Packaging Services Market: Breakup by Packaging Type (in %), 2014
  • Figure 5.20: Global-Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.21: Global-Healthcare Cold Chain Instrumentation Services Market (in Billion US$), 2004-2014
  • Figure 5.22: Global-Healthcare Cold Chain Instrumentation Services Market: Breakup by Instrumentation Type (in %), 2014
  • Figure 5.23: Global-Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.24: Global-Healthcare Cold Chain Logistic Spending by Region (in US$ Billion), 2012, 2014, 2016, 2018 and 2020
  • Figure 5.25: North America-Healthcare Cold Chain Logistic Services Market-(in Billion US$), 2008-2014
  • Figure 5.26: North America-Healthcare Cold Chain Logistic Services Market Forecast-(in Billion US$), 2015-2020
  • Figure 5.27: Europe-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2014
  • Figure 5.28: Europe-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.29: Asia Pacific-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2014
  • Figure 5.30: Asia Pacific-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.31: Rest of the World-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2014
  • Figure 5.32: Rest of the World-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 6.1: Global-Healthcare Cold Chain Products Market-Breakup by Segment (in %), 2007-2014
  • Figure 6.2: Global-Healthcare Cold Chain Products Market Forecast-Breakup by Segment (in %), 2015-2020
  • Figure 6.3: Global-Biopharmaceutical Market (in Billion US$), 2007-2014
  • Figure 6.4: Global-Biopharmaceutical Market Forecast (in Billion US$), 2015-2020
  • Figure 6.5: Global-Biosimilar Sales and Forecast (in Million US$), 2014 and 2020
  • Figure 6.6: Global-Share of Biopharmaceutical Manufacturers Outsourcing Some Production to Contract Manufacturers (in %), 2006 and 2011
  • Figure 6.7: Global-Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2011-2014
  • Figure 6.8: Global-Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2015-2020
  • Figure 6.9: Global-Vaccine Market (in Billion US$), 2007-2014
  • Figure 6.10: Global-Vaccine Market Forecast (in Billion US$), 2015-2020
  • Figure 6.11: Global-Vaccine Production Volume by Region (in %), 2008*
  • Figure 6.12: Europe-Vaccine Export Volume by Region (in %), 2008*
  • Figure 6.13: Global-Clinical Trials Market (in Billion US$), 2007-2014
  • Figure 6.14: Global-Clinical Trials Market-Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2009-2014
  • Figure 6.15: Time Taken for Biopharmaceuticals to Get Approved (in Months), 1982-2009
  • Figure 6.16: Global-Clinical Trials Market Forecast (in Billion US$), 2015-2020
  • Figure 6.17: Global-Clinical Trials Market Forecast-Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2015-2020
  • Figure 6.18: Number of Multinational Clinical Trials (Phase II and III) in Asian Countries by the Top Twenty Global Pharmaceutical Companies*
  • Figure 6.19: Global-Breakup of Biopharmaceuticals and Small Molecule Drugs in Preclinical & Clinical trials, (in %), 2009
  • Figure 6.20: Top Reasons for Conducting Clinical Trials in Each Country (in %), 2009
  • Figure 7.1: Financing Sources and Gaps (in %), 2008-2010
  • Figure 8.1: Global-Exports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007-2013
  • Figure 8.2: Global-Exports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007-2013
  • Figure 8.3: Global-Exports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons), 2007-2013
  • Figure 8.4: Global-Exports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007-2013
  • Figure 8.5: Global-Exports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007-2013
  • Figure 8.6: Global-Exports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007-2013
  • Figure 8.7: Global-Exports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in Tons), 2007-2013
  • Figure 8.8: Global-Temperature Sensitive Healthcare Products: Vaccines for Human Use: Export Volume Breakup by Country (in %), 2013
  • Figure 8.9: Global-Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Export Volume Breakup by Country (in %), 2013
  • Figure 8.10: Global-Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Export Volume Breakup by Country (in %), 2013
  • Figure 8.11: Global-Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations: Export Volume Breakup by Country (in %), 2013
  • Figure 8.12: Global-Temperature Sensitive Healthcare Products: Insulin in Dosage: Export Volume Breakup by Country (in %), 2013
  • Figure 8.13: Global-Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Export Volume Breakup by Country (in %), 2013
  • Figure 8.14: Global-Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Export Volume Breakup by Country (in %), 2013
  • Figure 8.15: Global-Imports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007-2013
  • Figure 8.16: Global-Imports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007-2013
  • Figure 8.17: Global-Imports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons), 2007-2013
  • Figure 8.18: Global-Imports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007-2013
  • Figure 8.19: Global-Imports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007-2013
  • Figure 8.20: Global-Imports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007-2013
  • Figure 8.21: Global-Imports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in Tons), 2007-2013
  • Figure 8.22: Global-Temperature Sensitive Healthcare Products: Vaccines for Human Use: Import Volume Breakup by Country (in %), 2013
  • Figure 8.23: Global-Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Import Volume Breakup by Country (in %), 2013
  • Figure 8.24: Global-Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Import Volume Breakup by Country (in %), 2013
  • Figure 8.25: Global-Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations: Import Volume Breakup by Country (in %), 2013
  • Figure 8.26: Global-Temperature Sensitive Healthcare Products: Insulin in Dosage: Import Volume Breakup by Country (in %), 2013
  • Figure 8.27: Global-Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Import Volume Breakup by Country (in %), 2013
  • Figure 8.28: Global-Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Import Volume Breakup by Country (in %), 2013

List of Tables

  • Table 3.1: Various Regulations on Healthcare Cold Chain Logistic Requirements
  • Table 4.1: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
  • Table 4.2: Dry Ice Containers
  • Table 4.3: Refrigerated Shipping Containers with Gel Packs
  • Table 4.4: Costs Associated With the Cold Chain Shipment of Healthcare Products, 2015*
  • Table 4.5: Costs Associated With the Non-Cold Chain Shipment of Healthcare Products, 2015
  • Table 5.1: Cold Chain Logistics: Comparison Matrix for Transport Modes
  • Table 6.1: Global-Healthcare Cold Chain Products Market-Breakup by Segment (in Billion US$), 2007-2014
  • Table 6.2: Global-Healthcare Cold Chain Products Market Forecast-Breakup by Segment (in Billion US$), 2015-2020
  • Table 6.3: Global-Biopharmaceutical Market-Sales by Class (in Billion US$), 2007-2014
  • Table 6.4: Global-Biopharmaceutical Market Forecast- Sales by Class (in Billion US$), 2015-2020
  • Table 6.5: Stability of Various Biopharmaceuticals at Room Temperature
  • Table 6.6: Complexity of the Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
  • Table 6.7: Temperature Stability of Commonly Used Vaccines
  • Table 6.8: The Effect of Temperature Excursions on the Usability of Vaccines
  • Table 6.9: Global-Major Vaccine Production Sites (in Numbers), 2008*
  • Table 6.10: Ideal Storage Temperatures for Clinical Trial Materials
  • Table 7.1: Cold Chain & Logistic Funding Gaps Per Infant (in US$), 2008-2010
Back to Top